Welcome to PsychU!

Long-Acting Injectables For The Treatment Of Bipolar I Disorder: Relevant Questions From Providers

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Long-Acting Injectables For The Treatment Of Bipolar I Disorder: Relevant Questions From Providers

Join us for this lively discussion with Dr. Joseph Goldberg and Dr. Mauricio Tohen regarding long-acting injectables (LAIs) in the treatment of bipolar I disorder. This moderated session will explore perception, preferences, challenges, and treatment goals for both patients and providers. Discussants will review provider and patient centric perspectives in selecting therapy, plus potential strategies to assess preferences regarding new preventative treatments such as mode of administration, dosing regimen and treatment-related determinants of adherence.


  • Describe the challenges to long-term treatment and the importance of management options in patients diagnosed with Bipolar I Disorder (BP-I)
  • Discuss the pros and cons of LAIs for patients living with BP-I, from the provider and patient perspective
  • Understand strategies to aid in shared decision making between providers and patients when considering LAIs



Joseph Goldberg, MD

Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

Dr. Goldberg currently serves as the Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and serves on the Board of Directors for the American Society of Clinical Psychopharmacology. Dr. Goldberg has published over 200 peer-reviewed papers on topics related to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology.

Mauricio Tohen, MD, DrPH, MBA

Chairman, Department of Psychiatry, University Distinguished Professor, University of New Mexico Health Science Center

Dr. Tohen is a Distinguished University Professor at the University of New Mexico and the Chairman of the University of New Mexico’s Department of Psychiatry and Behavioral Sciences. With more than 350 publications and 20,000 scientific citations to his name, Dr. Tohen received in 2016 the Mogens Schou Award for Education and Teaching from the International Society for Bipolar Disorders. In 2017, Dr. Tohen was recognized as one of the world’s leading experts on bipolar disorder based on the breadth and depth of his publications. He earned his medical degree from the National University of Mexico and his Doctorate in Public Health (Epidemiology) from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto, where he additionally obtained a DPsych (Diploma) in Psychiatric Research, and a fellowship at McLean Hospital, Harvard Medical School in Psychopharmacology. Dr. Tohen also obtained an MBA degree from the Indiana University Kelly School of Business.

Michael Aldape, PhD (OPDC)

Senior Medical Science Liaison

Joseph Goldberg, MD and Mauricio Tohen, MD, DrPH, MBA are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Michael Aldape, PhD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.



Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders